Research programme: prostaglandin E2 antagonists - deCODE geneticsAlternative Names: DG 061
Latest Information Update: 31 Jan 2013
At a glance
- Originator deCODE genetics
- Mechanism of Action Dinoprostone receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Feb 2006 Preclinical trials in Pain in Iceland (PO)